Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: Characterization and clinical associations

Rheumatology International

Volumn 26, Issue 2, 2005, Pages 107-114

  Manolova, Irena ^a   Dantcheva, Maria ^b  

^a University Hospital   (Bulgaria)

^b TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

Antineutrophil cytoplasmic antibodies; Immunoglobulin G subclass distribution; Rheumatoid arthritis

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; C REACTIVE PROTEIN; CATHEPSIN G; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTOFERRIN; LEUKOCYTE ELASTASE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; BULGARIA; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BULGARIA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 28844445265     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0517-2     Document Type: Article

References (47)

1. Rasmussen N, Wiik A, Hoier-Madsen M, Borregaard N, van der Woud F (1988) Anti-neutrophil cytoplasm antibodies. Lancet I: 706-707
2. Van der Woud FJ, Daha MR, Van Es LA (1989) The current status of neutrophil cytoplasmic antibodies. Clin Exp Immunol 78: 143-148
3. Jennette JC, Hoidal JH, Falk RJ (1990) Specificity of antineutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75: 2263-2264
4. Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318: 1651-1657
5. Lesavre P (1991) Antineutrophil cytoplasmic antibodies antigen specificity. Am J Kidney Dis 18: 159-163
6. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, Van Es LA, Van der Giessen M, Van der Hem GK (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet i: 425-429
7. Savage COS, Winearls CG, Jones SJ, Marshall PD, Lockwood CM (1987) Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet i: 1389-1393
8. Wong RCW, Silvestrini RA, Savige JA, Fulcher DA, Benson EM (1999) Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns. J Clin Pathol 52: 124-128
9. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW (1994) Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 46: 1-15
10. Nassberger L, Sjoholm AG, Sturfelt G (1990) Absence of circulating antineutrophil cytoplasm antibodies (ANCA) in severe vasculitis associated with rheumatoid arthritis. Scand J Rheumatol 19: 189-192
11. Savige JA, Gallicchio MC, Stockman A, Cunningham TJ, Rowley MJ, Georgiou T, Davies D (1991) Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis. Clin Exp Immunol 86: 92-98
12. Braun MG, Csernok E, Schmitt WH, Gross WL (1996) Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol 23:826-830
13. Mustila A, Paimela L, Leirisalo-Repo M, Huhtala H, Miettinen A (2000) Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive disease. Arthritis Rheum 43: 1371-1377
14. Mulder AHL, Horst G, van Leeuwen MA, Limburg PC, Kallenberg CGM (1993) Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Arthritis Rheum 36:1054-1060
15. Cambridge G, Williams M, Leaker B, Corbett M, Smith CR (1994) Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass. Ann Rheum Dis 53: 24-29
16. Mustila A, Korpela M, Mustonen J, Helin H, Huhtala H, Soppi E, Pasternack A, Miettinen A (1997) Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy. Arthritis Rheum 40:710-717
17. Rother E, Schochat T, Peter HH (1996) Antineutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis: a prospective study. Rheumatol Int 15:231-237
18. Chikazawa H, Nishiya K, Matsumori A, Hashimoto K (2000) Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases. J Clin Immunol 20: 279-286
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
20. van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, van Rijswijk MH, van de Putte LB (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49: 916-920
21. van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL (1996) Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 39:34-40
22. Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-662
23. Wiik A (1989) Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 97 [Suppl 6]: 12-13
24. Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage COS, Silvestrini R, van der Woude F, Wieslander J, Wiik A (1999) International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111: 507-513
25. Manolova I, Dancheva M, Halacheva K (2001) Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity and clinical associations. Rheumat Int 20: 197-200
26. Manolova I, Dancheva M, Halacheva K (2002) Predominance of IgG1 and IgG3 subclasses of antibodies to neutrophil cytoplasmic antigens in patients with systemic lupus erythematosus: prevalence, antigen specificity and clinical associations. Rheumat Int 21: 227-233
27. Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL (1995) Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Arthritis Rheum 38: 633-637
28. Chowdhury SM, Broomhead V, Spickett GP, Wilkinson R (1999) Pitfalls of formalin fixation for determination of antineutrophil cytoplasmic antibodies. J Clin Pathol 52:475-477
29. Brimnes J, Halberg P, Jacobsen S, Wiik A, Heegaard NHH. (1997) Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin Exp Immunol 110:250-256
30. Afeltra A, Sebastiani GD, Galeazzi M, Caccavo D, Ferri GM, Marcolongo R, Bonomo L (1996) Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis. J Rheumatol 23: 10-15
31. Cooper T, Savige J, Nassis L, Paspaliaris B, Neeson P, Neil J, Knight KR, Daskalakis M, Doery JCG (2000) Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/ permeability-increasing protein and azurocidin. Rheumatol Int 19: 129-136
32. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126: 866-873
33. Uesugi H, Ozaki S, Sobajima J, Osakada F, Shirakawa H, Yoshida M, Nakao K (1998) Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J Rheumatol 25:703-709
34. Ellerbroek PM, Oudkerk Pool M, Ridwan BU, Dolman KM, von Blomberg BM, von dem Borne AE, Meuwissen SG, Goldschmeding R (1994) Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol 47: 257-262
35. Bansi DS, Fleming KA, Chapmam RW (1996) Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass. Gut 38: 384-389
36. Brouwer E, Cohen Tervaert JW, Horst G, Huitema MG, Van Der Giessen M, Limburg PC, Kallenberg CGM (1991) Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 83: 379-386
37. Segelmark M, Wieslander J (1993) IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA). Nephrol Dial Transplant 8: 696-702
38. Cohen PL, Cheek RL, Hadler JA, Yount WJ, Eisenberg RA (1987) The subclass distribution of human IgG rheumatoid factor. J Immunol 139:1466-1471
39. Vasiliauskiene L, Wiik A, Hoier-Madsen M (2001) Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis. Ann Rheum Dis 60: 459-466
40. Vittecoq O, Jouen-Beades F, Krzanowska K, Bichon-Tauvel I, Menard JF, Daragon A, Gilbert D, Tron F, Le Loet X (2000) Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis. Rheumatology 39: 481-489
41. Coremans IE, Hagen EC, Daha MR, van der Woude FJ, van der Voort EA, Kleijburg-van der Keur C, Breedveld FC (1992) Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arhtritis Rheum 35: 1466-1475
42. Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Antineutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87: 4115-4119
43. Keogan MT, Esnault VLM, Green AJ, Lockwood CM, Brown DL (1992) Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 90: 228-234
44. Mulder AHL, Heeringa P, Brouwer E, Limburg PC, Kallenberg CGM (1994) Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a FcγRII-dependent process. Clin Exp Immunol 98: 270-278
45. Peen E, Sundqvist T, Skogh T (1996) Leukocyte activation by anti-lactoferrin antibodies bound to vascular endothelium. Clin Exp Immunol 103: 403-407
46. Roozendaal C, Horst G, Pogany K, van Milligen de Wit AW, Kleibeuker JH, Haagsma EB, Limburg PC, Kallenberg CG (1998) Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis. Adv Exp Med Biol 43: 313-319
47. Zweiman B, von Allmen C (1999) Comparative effects of lactoferrin antibodies and tumor necrosis factor on neutrophil adherence to matrix proteins. Clin Diagn Lab Immunol 6:364-368